Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA.

Combined a-TEA-LS + aPD-L1 therapy was associated with a slight decrease in tumor size ( Figure 2A ) and some improved survival ( Figure 2B ), though these did not reach statistical significance.

also in 111,027 other papers